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ABSTRACT: Sugar fatty acid esters are increasingly used as excipients in 
pharmaceutical products, but few data are available on their toxicity profile, mode of 
action and efficacy on intestinal epithelial models. Three water soluble sucrose 
esters, palmitate (P-1695), myristate (M-1695), laurate (D-1216), and two reference 
absorption enhancers, Tween 80 and Cremophor RH40 were tested on Caco-2 cells. 
Caco-2 monolayers formed a good barrier as reflected by high transepithelial 
resistance and positive immunostaining for junctional proteins claudin-4, ZO-1 and β-
catenin. Sugar esters in non-toxic concentrations significantly reduced resistance 
and impedance, and increased permeability for atenolol, fluorescein, vinblastine, 
caffeine, antipyrine and rhodamine 123 in Caco-2 monolayers. No junctional opening 
was induced by sucrose esters assessed by immunohistochemistry and electron 
microscopy, but some alterations were seen in the structure of F-actin microfilaments. 
It was demonstrated for the first time that sucrose esters fluidize the plasma 
membrane of living epithelial cells in low concentrations. They enhanced the 
accumulation of efflux transport r ligands rhodamine 123 and calcein AM in cells 
when co-administered, but not in pr treatment. These data indicate that in addition to 
their dissolution increasing properties sugar esters can enhance drug permeability 
through both the transcellular and paracellular routes without direct effect on efflux 
pumps. 
 
 
Keywords: absorption enhancer, Caco-2 cells, drug permeability, efflux pumps, epithelial, 
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INTRODUCTION 
Drug delivery across biological barriers, like intestine or blood-brain barrier remains a great 
challenge in pharmaceutical research. One of the options to improve permeability of low 
penetrating active agents is the use of absorption enhancers.1 Among the non-ionic surface 
active agents used for this purpose ethoxylated sorbitans (e.g. Tween 80) and castor oil esters 
(e.g. Cremophor RH40) have been widely investigated and were demonstrated to enhance the 
solubility or absorption of drugs.2,3 Clinically employed surfactants applied in pharmaceutical 
industry as absorption enhancers have several advantageous properties4 but can also cause 
side-effects in vivo.4-6 There is a need for new, innovative absorption enhancers with more 
favourable profile and fever drawbacks. 
Sucrose fatty acid esters are non-ionic surfactants which are present naturally in plants 
and microorganisms.7 For industrial purposes they are synthesized by esterification of fatty 
acids with sucrose.8 Food industry applies them as food emulsifiers and food additives for 
breads, cakes, pastas, noodles, baby’s foods, ice creams in the last 40 years.9,10 Cosmetic 
industry also employs them because of low skin irritation, excellent emulsification and 
solubilizing properties.11 
Sugar esters are promising candidates for improving the solubility and permeability of 
active agents in pharmaceutical technology as recently reviewed by Szűcs and Szabó-
Révész.12 In recent decades sucrose esters due to their excellent emulsifier and surfactant 
properties were tested for transdermal drug delivery using various formulations including 
microemulsions and reversed vesicles.13-17 These surfactants form micelles18 and have also 
been used to prepare nanovehicles, like nanodispersions, nanosuspensions and niosomes.19-22 
The use of sucrose esters for oral application was less studied. Controlled release from matrix 
tablets containing sucrose esters was demonstrated.23 Daunomycin accumulation was 
effectively enhanced by sugar esters in Caco-2 intestinal cells.24 In animal studies sucrose 
esters improved the intestinal permeability of different types of active agents, like the 
polypeptide hormone calcitonin,25 lidocaine hydrochloride26 and cyclosporine A.27 The 
intestinal absorption of water soluble paracellular marker dextran was also enhanced by L-
1695 laurate ester treatment in rats.28 Although the paracellular barrier in intestinal cells is 
regulated by intercellular junctions4 changes in tight or adherens junctions following sucrose 
fatty acid ester treatments have not been investigated yet, and the affected transport pathways 
were not elucidated. Sugar esters were also described to inhibit efflux pump proteins, mainly 
P-glycoprotein (P-gp, ABCB1) in epithelial cells and in animal experiments.29,30 While the 
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effect of sucrose esters on cell membranes was hypothesized24 it was not investigated in 
living cells yet. 
The human Caco-2 cell line is a widely used model of the epithelium of small intestine. 
Cells are polarised, grow in monolayer, possess microvilli, make tight connections with 
adjacent cells by their tight and adherens junction structures and express many nutrient and 
efflux transporters such as P-gp.31-33 Caco-2 cells are widely used to measure drug 
permeability and data correlate well with in vivo drug absorption, mostly in case of passive 
transcellular pathway.31,34,35 
Our aim was to test the effects of three different, palmitate (P-1695), myristate (M-
1695) and laurate (D-1216) sucrose esters on the viability, passive permeability, junctional 
and cytoskeletal morphology, membrane fluidity and efflux pump activity of Caco-2 
intestinal epithelial cells and compare with reference absorption enhancers Tween 80 and 
Cremophor RH40. The toxicity of surfactants was determined by standard colorimetric end-
point assays. The paracellular barrier properties were tested by resistance and real-time 
impedance measurements. To assess passive as well as efflux transport across epithelial 
monolayers the following markers and drugs were examined in the presence or absence of 
surfactants: fluorescein, atenolol, caffeine, antipyrine, vinblastine and rhodamine 123. 
Cellular and junctional morphology in sugar ester-treated Caco-2 cells was monitored by 
immunostaining for junctional proteins claudin-1, zonula occludens protein-1 (ZO-1), β-
catenin and transmission electron microscopy for the first time to our best knowledge. 
Arrangement of filamentous actin (F-actin) a main cytoskeletal protein contributing to normal 
organization of tight and adherens junctions was also investigated after treatments with 
absorption enhancers. Plasma membrane fluidity in living Caco-2 cells in the presence of 
surfactants was also checked for the first time. Rhodamine 123 and calcein AM fluorescent 
markers were used for efflux pump experiments. 
MATERIALS AND METHODS 
Materials 
All reagents were purchased from Sigma-Aldrich Ltd., Hungary, unless otherwise indicated. 
Laurate sucrose ester (D-1216) was of pharmaceutical grade, palmitate (P-1695) and 
myristate (M-1695) sucrose esters were of analytical grade (Mitsubishi Kagaku Foods Co., 
Tokyo Japan). Tween 80 and Cremophor RH40 (BASF, Ludwigshafen am Rhein, Germany) 
Page 4 of 43
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
were of pharmaceutical grade. Table S1 summarizes some of properties of the surfactants 
employed in the study. 
Cell culture 
Human intestinal epithelial Caco-2 cell line (ATCC cat.no. HTB-37, USA) was used in the 
experiments. To obtain a more uniform morphology and higher efflux pump expression cells 
were treated with vinblastine (10 nM) for at least 6 passages as described by Hellinger et al. 
(2010).34 Cells were grown in Eagle’s minimal essential medium (Gibco, Life Technologies, 
Carlsbad, CA, USA) supplemented with 10 % fetal bovine serum (Lonza, Basel, Switzerland), 
sodium-pyruvate (Gibco, Life Technologies, Carlsbad, CA, USA) and 50 µg/ml gentamicin 
in a humidified 37°C incubator with 5 % CO2. Cells were seeded in culture dishes at a 
density of 5 × 104 cells/cm2 and the medium was changed every 2 days. When cells reached 
approximately 80 - 90 % confluence in the dish they were subcultured with 0.05 % trypsin-
EDTA solution. For the cytotoxicity assays cells were cultured in 96-well plates (Orange 
Scientific, Braine-l’Alleud, Belgium) and for real-time cell electronic sensing (RT-CES) 96-
well plates with gold electrodes (E-plate 96, ACEA Biosciences, San Diego, USA) were 
used. For electric resistance measurements and permeability studies Caco-2 cells were 
cultured on Transwell inserts (polycarbonate membrane, 0.4 µm pore size, 1.12 cm2 surface 
area, Corning Life Sciences, Tewksbury, MA, USA). For staining of nuclei, junctions and F-
actin cells were grown on glass coverslips (Menzel-Gläser, Braunschweig, Germany). All 
surfaces were coated with 0.05 % rat tail collagen before cell seeding, unless otherwise 
indicated. 
Cell viability measurements 
Treatment doses of sucrose esters P-1695, M-1695 and D-1216 varied between 3-3,000 
µg/ml. The reference absorption enhancers were used in 1-100,000 µg/ml concentrations. 
Treatment solutions were prepared in Dulbecco’s Modified Eagle Medium without phenol 
red (DMEM; Life Technologies, Carlsbad, CA, USA). Triton X-100 in 10 mg/ml dose was 
used as a toxicity control.  
MTT dye (3-(4,5-dimethyltiazol-2-yl)-2,5-diphenyltetrazolium bromide) conversion 
was used to measure cell metabolic activity and viability. Caco-2 epithelial cells were 
cultured in 96-well plates for 3 days. Confluent cultures were treated for 1 or 24-hours, 
washed with phosphate buffered saline (PBS; pH: 7.4) and incubated with 0.5 mg/ml MTT 
solution for 3 hours in a CO2 incubator. The amount of blue formazan crystals converted by 
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cells was dissolved in dimethyl-sulfoxide and determined by measuring absorbance at 
595 nm wavelength with a microplate reader (Fluostar Optima, BMG Labtechnologies, 
Ortenberg, Germany). Cell viability was calculated as percentage of dye conversion by non-
treated cells. 
Lactate dehydrogenase (LDH) release, the indicator of cell membrane damage, was 
determined from culture supernatants by “Cytotoxicity detection kit (LDH)” (Roche, Basel, 
Switzerland). Caco-2 cells cultured in 96-well plates for 3 days were treated for 1 or 24-hours 
with absorption enhancers, then 50 µl samples from culture supernatants were incubated with 
equal amounts of reaction mixture for 15 minutes. The enzyme reaction was stopped by 
0.1 M HCl. Absorbance was measured at a wavelength of 492 nm with a microplate reader 
(Fluostar Optima, BMG Labtechnologies, Ortenberg, Germany). Cell death was calculated as 
percentage of the total LDH release from cells treated by 10 mg/ml Triton X-100. The non 
toxic concentrations (TC0), 50 % toxic concentrations (TC50) and concentrations causing 
death in all cell (TC100) were calculated from fitted curves (GraphPad Prism 5.0, GraphPad 
Software Inc., San Diego, CA, USA). 
Measurement of electrical resistance and impedance of cell layers 
Transepithelial electrical resistance (TEER), representing the permeability of tight junctions 
for ions, mostly sodium in culture conditions, was measured by an EVOM resistance meter 
using STX-2 electrodes (World Precision Instruments Inc., Sarasota, FL, USA), and it was 
expressed relative to the surface area (Ω × cm2). The TEER of intestinal epithelial cell 
monolayers was 800±138 Ω × cm2 (mean±SD; n=158) after 3 weeks of culture. Resistance 
measurements were carried out before and after permeability studies to check the barrier 
integrity.  
RTCA SP (ACEA Biosciences, San Diego, USA) instrument was used for the 
measurement of impedance at 10 kHz. The interaction between cells and gold electrodes of 
E-plates generates impedance response which correlates with ion flux.36 Impedance non-
invasively quantifies proliferation, viability or permeability of adherent cells in real-
time.37,38,6 E-plates were coated with 0.2 % gelatine-PBS solution for 20 minutes at 37°C. 
Culture medium (80 µl) was added to each well for background readings then 80 µl cell 
suspension was dispensed at the density of 6 × 103 cells/well. The cells were kept in 
incubator at 37°C for 48 hours and monitored every 5 minutes. The impedance at each time 
point was defined as Rn - Rb, where Rn is the cell-electrode impedance of the well when it 
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contains cells and Rb is the background impedance of the well with the medium alone. During 
treatments cells impedance was measured every 2 minutes.  
Permeability study 
The flux of the drugs caffeine, antipyrine, atenolol, vinblastine and fluorescent dyes 
fluorescein and rhodamine 123 across epithelial cell layers was determined in permeability 
studies. Caco-2 cells were seeded onto Transwell filter inserts and the resistance of the cell 
layers was checked twice a week. After 21 days when the resistance was high and stable, the 
inserts were transferred to 12-well plates containing 1.5 ml Ringer–Hepes solution (150 mM 
NaCl, 6 mM NaHCO3, 5.2 mM KCl, 2.2 mM CaCl2, 0.2 mM MgCl2, 2.8 mM D-glucose, 
5 mM Hepes, pH 7.4) in the basolateral compartments. In apical chambers culture medium 
was replaced by 500 µl Ringer–Hepes containing drugs or marker molecules with or without 
absorption enhancers. The drugs and rhodamine 123 were used at the dose of 10 µM, 
fluorescein was administered at 10 µg/ml (30 µM) concentration. The concentrations of 
absorption enhancers chosen for permeability assays were in the non-toxic range: Tween 80 
and Cremophor RH40 were used at 30, 60, 100, 1000 µg/ml, P-1695 and M-1695 at 30, 
60 µg/ml, and D-1216 at 30, 60, 100 µg/ml. The plates were kept in a CO2 incubator for 1 
hour on a rocking platform (100 rpm). For rhodamine 123 bidirectional transport was 
determined. After the incubation samples from the upper and lower compartments were 
collected and the concentrations of fluorescein and rhodamine 123 were determined by a 
fluorescent microplate reader (Fluostar Optima) while drug concentrations were measured by 
HPLC, as detailed below. The apparent permeability coefficient (Papp) in apical to basal (AB) 
direction was calculated by this equation: 
[ ]
[ ] tCA
VC
A
××
×
=
BB
(cm/s) Papp  
where [C]B is the concentration of the tracer in the basal compartment after 1 hour; [C]A is the 
concentration in the apical compartment at 0 hour; VB is the volume of the basal 
compartment (1.5 ml); A is the surface area available for transport (1.12 cm2); t is the length 
of the time of the transport assay (1 hour). To calculate the apparent permeability of the 
opposite transport direction (BA) the following equation was used: 
[ ]
[ ] tCA
VC
B
××
×
=
AA
(cm/s) Papp  
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where [C]A was the concentration of the tracer in apical compartment after 1 hour; [C]B is the 
concentration in basal compartment at 0 hour, and VA is the volume of the apical 
compartment (0.5 ml). 
HPLC analytical procedures 
Analytical measurements were performed on a Merck-Hitachi LaChrom HPLC system 
equipped with UV and fluorescence detector (Merck, Darmstadt, Germany). Antipyrine and 
vinblastine were determined by using Purospher C18e 125 mm×3 mm (5 µm) column (Merck, 
Darmstadt, Germany) operated at 0.5 ml/min flow rate, maintained at 40 ºC. Mobile phase for 
antipyrine consisted of 40 % methanol in 0.1 M ammonium acetate with isocratic elution. UV 
detection was at 250 nm wavelength. For vinblastine, elution was applied to a mixture of 
250 ml methanol, 200 ml 25 nM ammonium-acetate and 3 ml 10 % trifluoroacetic acid. 
Vinblastine was quantified at 275/360 nm excitation/emission wavelengths. HPLC 
measurement of caffeine was performed using Purospher C18e 125 mm×4 mm (5 µm) 
column (Merck, Darmstadt, Germany) operated at 0.8 ml/min flow rate, maintained at 35 ºC. 
Mobile phase was 15 % methanol in 0.1 M ammonium acetate. UV detection was at 275 nm. 
Samples with atenolol were injected onto a Gemini C18e 150 mm×3 mm (5 µm) column 
(Phenomenex Inc., Aschaffenburg, Germany) operated at 35°C and at an eluent flow rate of 
0.5 ml/min. Elution was applied to a mixture of 300 ml methanol, 400 ml 0.1 M ammonium-
acetate, 20 ml 10 % ammonium hydroxide and 2 ml 0.1 M Na2EDTA. Atenolol was 
quantified at 230/300 nm excitation/emission wavelengths. 
Fluorescent and immunostainings 
Morphology and cell-cell connections of Caco-2 cells were confirmed by immunostaining for 
tight junction protein claudin-1, cytoplasmic linker protein zonula occludens 1 (ZO-1) and 
adherens junction protein β-catenin. Filamentous actin was stained by fluorescently labelled 
phalloidin, and cell nuclei by bis-benzimide dye (Hoechst dye 33342). Cell layers were 
grown on glass coverslips and treated with absorption enhancers (P-1695 30 µg/ml, M-1695 
60 µg/ml, D-1216 100 µg/ml, Tween 80 and Cremophor RH40 1000 µg/ml) for 1 hour. 
Cytochalasin D, an inhibitor of actin polymerization was applied at 2 µg/ml concentration. 
After treatments the cultures were washed twice in PBS and fixed with 4 % 
paraformaldehyde-PBS for 30 minutes. Cells were blocked with 3 % bovine serum albumin 
in PBS and incubated with primary antibodies anti-claudin-1, anti-ZO-1 and anti-β-catenin 
(Life Technologies, Carlsbad, CA, USA) overnight. Incubation with secondary antibody Cy3-
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labeled anti-rabbit IgG, Alexa Fluor 488 Phalloidin (Life Technologies, Carlsbad, CA, USA) 
and bis-benzimide lasted for 1 hour. Between and after incubations cells were washed three 
times with PBS. Coverslips were mounted by Fluoromount and staining was examined by a 
Leica SP5 confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany). 
Electron microscopy 
Cells grown on culture inserts were treated with absorption enhancers (P-1695 30 µg/ml, M-
1695 60 µg/ml, D-1216 100 µg/ml, Tween 80 and Cremophor RH40 1000 µg/ml) for 1 hour. 
After treatments cells were washed by PBS and fixed with 3% paraformaldehyde containing 
0.5% glutaraldehyde in cacodylate buffer (pH 7.4) for 30 min at 4°C. After washing with the 
buffer several times, cells were postfixed in 1% OsO4 for 30 min. Following a rinse with 
distilled water, the cells were dehydrated in graded ethanol, block-stained with 1% uranyl 
acetate in 50% ethanol for 1 h. After the last step of dehydration, inserts were placed in the 
1:1 mixture of ethanol and Taab 812 (Taab; Aldermaston, Berks, UK) for 30 min at 30°C. 
Finally, the membranes of the culture inserts with the cells were removed from their support 
and embedded in Taab 812. Polymerization was performed overnight at 60°C. Ultrathin 
sections were cut perpendicularly for the membrane using a Leica UCT ultramicrotome 
(Leica Microsystems, Milton Keynes, UK) and examined using a Hitachi 7100 transmission 
electron microscope (Hitachi Ltd., Tokyo, Japan) 
Measurement of plasma membrane fluidity in Caco-2 cells 
Caco-2 cells were collected by trypsinization, washed twice and resuspended in PBS. The 
density of cells was set by absorbance measurement at 360 nm to OD360=0.1 (Hewlett 
Packard 8452A Diode Array Spectrophotometer). Cells were labeled with 0.2 µM TMA-DPH 
(1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene; Molecular Probes, Life 
Technologies) for 5 minutes. Fluorescence anisotropy was measured on a T-format 
fluorescence spectrometer (Quanta Master QM-1, Photon Technology International, 
Princeton, NJ, USA). Excitation and emission wavelengths were 360 and 430 nm, 
respectively (5-nm slits). Cells were kept at 37°C under stirring conditions.39,40 Anisotropy 
data were acquired in every second. After 5 minutes the lowest concentrations of treatment 
solutions were added rapidly to the cell suspension and every 3 minutes the treatment 
concentration was increased during anisotropy measurements. Control cells received only 
vehicle. A strong membrane fluidizer, benzyl alcohol (30 mM) (Merck, Darmstadt, Germany) 
was used as a positive control in the experiments. The following treatment concentrations 
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were applied: 1, 10, 30, 60, 100 µg/ml for sucrose ester, and 1, 10, 100, 1000 µg/ml for 
Tween 80 and Cremophor RH40. The average of 50 anisotropy measurements in the last 1 
minute of each treatment concentration was calculated and compared to the anisotropy of the 
vehicle-treated cells at the same time point. 
Measurement of efflux pump activity 
The activity of efflux pumps was determined by cellular accumulation of rhodamine 123 and 
calcein AM (Life Technologies, Carlsbad, CA, USA) in Caco-2 epithelial cells grown in 24-
well plates for 2 days (seeding density: 105 cells/well). In the pre-treatment experiments cells 
were incubated with surfactants P-1695 (30 µg/ml), M-1695 (60 µg/ml), D-1216 (100 µg/ml), 
Tween 80 (1000 µg/ml), Cremophor RH40 (1000 µg/ml) or efflux pump inhibitors verapamil 
(100 µM) and cyclosporin A (10 µM) for 1 hour, then the cell layers were washed and 
incubated with 10 µM rhodamine 123 in Ringer-Hepes solution for another 1 hour. In the co-
treatment experiments, cells were pre-incubated with Ringer-Hepes buffer for 20 minutes. 
Treatments with surfactants or efflux pump inhibitors were done in the presence of 
rhodamine 123 for 1 hour. Following incubations cells were washed three times with ice cold 
PBS and lysed with 0.1 M NaOH in both types of experiments. Rhodamine 123 concentration 
was determined by a fluorescent microplate reader (excitation wavelength: 485 nm, emission 
wavelength: 520 nm; Fluostar Optima).  
The calcein AM assay can be used for the measurement of the activity of efflux 
transporters P-gp and multidrug resistance protein-1 or -2 (MRP-1, ABCC1).41,30 The cellular 
transport of the non-fluorescent calcein AM is inhibited by efflux transporters, therefore only 
limited amount gets into the cells where intracellular esterases convert the dye to a 
fluorescent metabolite. For calcein AM assay Caco-2 cells were seeded on 96-well plate (cell 
density: 7×104 cells/well) and grew for 24 hours. In the pre-treatment experiments cells were 
incubated for 1 hour with surfactants or efflux pump inhibitors. After the treatments cells 
were washed and the buffer solution was replaced with 1.25 µM calcein AM in Ringer-Hepes, 
and the plate was immediately placed in a microplate reader (Fluostar Optima). The 
fluorescence was measured at 5 minutes interval for 1 hour (excitation wavelength: 485 nm; 
emission wavelength: 520 nm). In the co-treatment experiments cells were pre-incubated with 
Ringer-Hepes for 20 minutes. Treatments with surfactants or efflux pump inhibitors were 
done in the presence of 1.25 µM calcein AM. The fluorescence was immediately measured 
by a microplate reader at 5 minutes interval for 1 hour. The fluorescence intensity was 
calculated as percentage of the control group. 
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Statistical analysis 
All data presented are means ± SD. Values were compared using analysis of variance 
followed by Dunnett’s test (GraphPad Prism 5.0, GraphPad Software Inc., San Diego, CA, 
USA). In case of anisotropy measurements two-way analysis of variance followed by 
Bonferroni posttest was applied. Changes were considered statistically significant at P < 0.05. 
All experiments were repeated at least two times, the number of parallel samples varied 
between 4 and 12.  
RESULTS 
Effect of sucrose esters on the viability of cultured epithelial cells 
Treatment of Caco-2 cells with sucrose esters dose- and time-dependently decreased MTT 
dye conversion indicating reduced cell viability (Fig. 1, Table 1). The doses above 30 µg/ml 
of palmitate or 60 µg/ml of myristate esters significantly reduced metabolic activity of Caco-
2 cells, while concentrations above 200 µg/ml resulted in cell death (Fig. 1a). D-1216 laurate 
ester was the least toxic among the investigated sucrose esters, the 100 µg/ml dose did not 
decrease epithelial cell viability, while 200 µg/ml to 600 µg/ml concentrations reduced MTT 
conversion in epithelial cells after 1 hour. The reference surfactants showed lower toxicity on 
epithelial cells. Tween 80 or Cremophor RH40 at 3,000 µg/ml concentration did not reduced 
cell viability of epithelial cells for 1 hour (Fig. 1a). Similar results were obtained by 
measurements of LDH enzyme release from treated cells indicating plasma membrane 
damage. The non-toxic concentrations for all sucrose esters were the same with both cell 
viability methods. Cell death was observed after 1-hour treatment above 300 µg/ml sucrose 
esters, but Tween 80 or Cremophor RH40 did not increase the enzyme release at any tested 
concentrations (Fig. 1b). Based on these results the following concentrations were considered 
as safe for 1 hour-treatments and applied in further experiments on Caco-2 epithelial cells: P-
1695 30 µg/ml, M-1695 60 µg/ml, D-1216 100 µg/ml, Tween 80 and Cremophor RH40 
1000 µg/ml. 
The concentrations of surfactants causing 50 % or complete cell death (TC 50 and TC 
100) at 24 hours were lower than for the 1-hour treatments (Table 1). The non-toxic doses of 
P-1695, M-1695 and D-1216 were about 20, 20 and 100 µg/ml, respectively, by both assays. 
The toxic concentrations of reference absorption enhancers were more than one order of 
magnitude higher than that of sucrose esters. The TC 0 values for Tween 80 were calculated 
as 473 µg/ml (MTT test) and 1068 µg/ml (LDH assay). The non-toxic concentrations of 
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Cremophor RH40 on Caco-2 cells for 24 h were 30,000 µg/ml and 2067 µg/ml determined by 
by MTT test and LDH assay, respectively (Table 1).  
Effect of sucrose esters on the electrical resistance and impedance of 
epithelial cell layers 
Non-toxic doses of sucrose esters but not of reference surfactants increased the ionic 
permeability across Caco-2 monolayers monitored by impedance and TEER measurements. 
Sugar esters reduced the impedance of epithelial cell layers measured by RTCA SP (Fig. 2a). 
The impedance decreased rapidly from the baseline of 125 Ω to 90 Ω within 30 minutes by P-
1695 (30 µg/ml) and D-1216 (100 µg/ml) treatments. M-1695 (60 µg/ml) also significantly 
reduced the impedance of Caco-2 layers. No significant change was caused by Tween 80 or 
Cremophor RH40. In accordance with the impedance measurements P-1695, M-1695 and D-
1216 reduced the resistance of the cell layers to 25 %, 55 % and 62 % as compared to control 
at 1-hour treatment (Fig. 2b). 
Effect of sucrose esters on Caco-2 permeability for drugs and 
fluorescein 
The permeability of hydrophilic atenolol (0.17 × 10-6 cm/s) and efflux pump ligand lipophilic 
vinblastine (0.62 × 10-6 cm/s) was low across Caco-2 cells (Table 2). Sucrose esters and 
reference surfactants significantly enhanced the penetration of atenolol and vinblastine across 
intestinal epithelial cell layers. The Papp of passive lipophilic drugs antipyrine (80.67 × 10
-6 
cm/s) and caffeine (87.59 × 10-6 cm/s) was high and the absorption enhancers did not increase 
it further (Table 2). 
The average apparent permeability coefficient of fluorescein was also low (0.78 x 10-6 
cm/s) in the control group. Using previously selected non-toxic concentrations for each 
surfactants, all investigated compounds caused significant increase in fluorescein flux across 
Caco-2 layers after 1-hour treatment (Fig. 2c). Myristate (60 µg/ml) and laurate sugar ester 
(100 µg/ml) doubled the flux of the marker molecule at 1-hour application. The increase in 
paracellular transport caused by palmitate sucrose ester (30 µg/ml) was smaller. Tween 80 
(1000 µg/ml) tripled the flux of fluorescein. Cremophor RH40 at similar dose enhanced the 
dye permeability to 164 %. Sucrose esters and reference absorption enhancers were also 
tested at 30, 60, and 100 µg/ml doses for 1 hour (Fig. S1a-c). The effect of sugar esters on the 
marker permeability was dose dependent (Fig. S1a-c). At 30 µg/ml concentration P-1695 and 
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M-1695 sucrose esters, but not the other surfactants (Fig. S1a), at 60 µg/ml concentration 
both myristate and laurate sugar esters increased the permeability of the marker dye 
(Fig. S1b). D-1216 at 100 µg/ml raised the fluorescein flux two times higher compared to 
control (Fig. S1c). In contrast to sucrose esters reference absorption enhancers in the 
concentration range of 30-100 µg/ml did not increase the permeability of fluorescein.  
Effects of sucrose esters on the epithelial intercellular junctions  
Claudin-1 transmembrane tight junction protein, ZO-1 cytoplasmic junctional linker protein, 
and β -catenin adherens junction protein all appeared at the cell-cell borders in a continuous, 
belt-like manner. Treatments with sucrose esters or reference surfactants for 1 hour did not 
affect the gross morphology of cells or intercellular junctions assessed by these 
immunostainings (Fig. 3a). No rupture of the interjunctions or fragmentation of the 
pericellular immunostaining was seen.  
F-actin structure was investigated in different regions of epithelial cells. At the level of 
tight junctions the cortical actin ring was sharply delineated in the control cells mimicking 
tight junction protein immunostainings (Fig. 3a). Following treatments with sucrose esters 
and reference absorption enhancers this F-actin staining near the tight junction region became 
wider and more blurred compared to control images. At the apical part of the cells the 
structure of microvilli was well shown by F-actin staining, which was preserved in all 
treatment groups (Fig. S2) At the basal part of cells staining of F-actin revealed long 
filaments organized in bunches (Fig. S2). This filamentous organization was less observed in 
the treatment groups, except for P-1695. Cytochalasin D, which inhibits actin polymerization 
changed the F-actin staining: dot-like aggregations appeared in the actin ring at the level of 
tight junctions and in the basal area (Fig. S2). Triton X-100 surfactant (1 %) disrupted the 
plasma membrane and the structure of microvilli at apical surface (Fig. S2). The junctional 
actin ring was mostly preserved, but aggregations were observed in the junctional and basal 
areas.  
The ultrastructure of tight intercellular junctions between Caco-2 cells was preserved in 
all treatment groups (Fig. 3b). No morphological change was seen by electron microscopy in 
the structure of apical microvilli, tight junctions, desmosomes, or interdigitations of adjacent 
epithelial cells. No open tight junctions were observed in the control or treatment groups by 
checking 140 electron micrographs (19-28 images/treatment group).  
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Effects of sucrose esters on plasma membrane fluidity in Caco-2 cells 
The membrane fluidity of living epithelial cells was determined by the measurement of 
fluorescence anisotropy of the cationic membrane probe TMA-DPH (Fig. 4). The anisotropy 
slightly decreased from 0.293±0.002 to 0.286±0.001 in vehicle-treated Caco-2 cells after 20 
minutes. The membrane fluidizer benzyl alcohol quickly and greatly reduced the anisotropy: 
TMA-DPH fluorescence anisotropy fell to 90.2% compared to control after 3 minutes. 
Sucrose esters fluidized the plasma membrane of Caco-2 cells at all investigated 
concentrations (Fig. 4a). A U-shaped dose-response curve was observed for all sucrose esters. 
The biggest change in anisotropy compared to the control group was measured at 10 µg/ml of 
P-1695 (92.0%), 30 µg/ml of M-1695 (91.9%) and 60 µg/ml of D-1216 (96.1%). 
Concentrations above these most effective doses resulted in higher anisotropy indicating 
reduced membrane fluidity.  
The reference absorption enhancers at 1 µg/ml concentration did not alter significantly 
membrane fluidity in contrast to sucrose esters (Fig. 4b). Tween 80 at 10 µg/ml was also 
ineffective, but at 100 µg/ml concentration and above statistically significantly fluidized the 
plasma membrane of epithelial cells with lowest anisotropy at 1000 µg/ml (94.2%). 
Cremophor RH40 was the most effective at 10 µg/ml dose (94.0%). Higher concentrations of 
the reference surfactants were also less effective to reduce membrane anisotropy. 
Effect of sucrose esters on efflux pump activity in Caco-2 cells 
Efflux transporter activity in Caco-2 cells (Fig. 5 and Fig. S3) was measured by the cellular 
uptake of calcein AM and the cellular uptake and bidirectional transport of rhodamine 123, a 
ligand of P-gp and BRCP.42 Co-administration of surfactants and rhodamine 123 resulted in 
statistically significant uptake of rhodamine (Fig. 5a). M-1695 and Tween 80 caused the 
highest, six-fold accumulation of the marker molecule compared to control. Simultaneous 
administration of sucrose esters and calcein AM significantly elevated the uptake of the 
ligand (200 – 245 %) (Fig. 5b). Co-treatment with Tween 80 (1000 µg/ml) also significantly 
increased the cellular accumulation of calcein AM. In contrast to rhodamine 123 uptake, 
Cremophor RH40 had no effect on calcein AM uptake (Fig. 5b). Verapamil (100 µM) and 
cyclosporin A (10 µM) significantly raised the level of both ligands in Caco-2 cells (Fig. 5a-
b). 
Pre-treatment with sucrose esters did not change the accumulation of rhodamine 123 in 
Caco-2 cells, but Tween 80 and Cremophor RH40 raised slightly the dye uptake to 133 % 
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and 117 %, respectively (Fig. S3a). Pre-treatment with surfactants did not increase 
significantly the uptake of calcein AM except for Tween 80 (113 %). Verapamil and 
cyclosporin A pre-treatment increased both rhodamine 123 and calcein AM accumulation in 
Caco-2 cells (Fig. S3). 
Rhodamine 123 permeability in apical-to-basal (AB) direction was significantly 
enhanced by both absorption enhancers and efflux pump inhibitors as compared to control 
group (0.82 ± 0.18 × 10-6 cm/s) (Fig. 5c-e). Treatments with sugar esters resulted in several 
fold elevated AB flux of the marker molecule as compared to reference surfactants or efflux 
pump inhibitors. The transport of rhodamine 123 in basal-to-apical (BA) direction was 
unchanged by P-1695 and D-1216, but increased by M-1695. In contrast, reference 
absorption enhancers and efflux pump inhibitors significantly decreased rhodamine 123 
permeability (Fig. 5d). Efflux ratios were calculated from the apparent permeability 
coefficients measured in BA and AB directions (BA/AB) (Fig. 5e). The ratio in the control 
group was 20.9 and all treatments decreased it significantly. 
DISCUSSION 
The potential use of sucrose esters as pharmaceutical excipients to improve drug 
solubilization and absorption has been recently reviewed.12 Several studies examined their 
application for transdermal drug delivery but there are only few papers on oral formulations 
using in vivo25-30 or in vitro24,29 models. The present study described the effect of three sugar 
esters with same hydrophilic-lipophilic balance (HLB) value of 16 but different fatty acid 
chain length (C12-C16) (Table S1) on cellular toxicity, drug permeability, intercellular 
junction morphology, efflux pump activity and plasma membrane fluidity, giving a more 
complex and detailed view on their action on cultured intestinal epithelial cells than previous 
works. 
Sucrose esters and viability of cultured epithelial cells 
Among the applied sucrose esters D-1216 laurate ester (C12) was the least toxic to human 
Caco-2 intestinal cells while myristate (C14) and palmitate (C16) ester had higher toxicity at 
both 1- or 24-hour treatments. The same results were obtained by these sugar esters in our 
previous works on Caco-2 human intestinal43 and on RPMI 2650 human nasal epithelial cell 
lines.38 This observation is also in agreement with a previous work in which an unspecified 
sucrose monoester at 50 µg/ml concentration was non-toxic to Caco-2 cells.44 The toxicity of 
sucrose laurate, Tween 80 and Cremophor RH40 was also studied on MDCK dog kidney 
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cells and two MDCK derived cell lines with high P-gp or MRP2 expression: laurate sucrose 
ester above 100 µg/ml caused cell damage, while Tween 80 and Cremophor RH40 were non-
toxic below 5000 µg/ml for 1.5 hour.30 In our previous study on Cremophor RH40 and EL 
similar results were obtained, treatment with Cremophor RH40 above 5000 µg/ml induced 
LDH release in intestinal epithelial and brain endothelial cells after 24 h.6 The toxic 
concentration of the reference surfactants was at least one order of magnitude higher in both 
our studies and in the literature indicating that Tween 80 and Cremophor RH40 have a safer 
toxicity profile on cultured cells than sucrose esters. 
In contrast to cell culture works ex vivo investigation of food grade sugar esters found 
no damages on palatal and buccal pork tissues.26 Animal studies indicate that sucrose fatty 
acid esters are hydrolysed by intestinal enzymes into sucrose and fatty acids in physiological 
conditions prior absorption and that their metabolites are not toxic.45-47 In addition sugar 
esters are chemically hydrolyzed under acidic or basic conditions48,49 and can be disintegrated 
by bacterial lipases.50 Tween 80 and Cremophor RH40 are also degraded in the intestine or in 
the blood,51,52 but the effects of the metabolites are unknown. A recent review drew the 
attention to the dangers of using surfactants as food additives: the permeability enhancing and 
efflux pump inhibitor properties of these emulsifiers may cause intestinal barrier dysfunction 
and increase the incidence of allergic and autoimmune disease,53 but conclusive animal 
studies and human data are missing. Despite the results of in vitro cell culture tests and the 
hypothesized dangers of surfactants ingested as additives in large quantities from foodstuff, 
the animal studies suggest that the toxicity of sucrose esters might be lower, if any, when 
given orally in small quantities as excipients. However, further chronic toxicity experiments 
are needed to prove the safety of sucrose esters as potential oral excipients. 
Sucrose esters and the permeability of intestinal epithelial cells 
The recommended HLB values for absorption enhancers in pharmaceutical applications is 
high.12,26 The tested surfactants possess high HLB (15-16), indicating a good potential 
penetration increasing effect. To determine the effect of sucrose esters on the para- and 
transcellular permeability and reveal the extent of the permeability increase different methods 
were used. 
The flux of ions, one of the most sensitive markers of paracellular permeability, can be 
measured by electrical resistance or impedance across epithelial cell layers. Both the 
resistance and impedance of epithelial cell layers were decreased by all three sucrose esters in 
non-toxic doses. Data from other studies also indicate that resistance of RPMI 2650 or Caco-
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2 cell layers dropped after treatment with sugar esters.38,44 We observed no significant 
changes in TEER or impedance by the reference surfactants in Caco-2 monolayers. 
Furthermore, two independent studies confirmed that lower and higher concentrations than in 
the present study did not decrease the resistance of Caco-2 cell layers.54,55 These data are in 
agreement with our previous works on RPMI 2650 38 and Caco-2 cells6. Based on the results 
of electrical resistance and impedance measurements sugar esters enhance the ion flux 
through cultured epithelial cell layers. 
Sucrose esters and reference absorption enhancers significantly increased the 
penetration of paracellular marker molecule fluorescein in a dose dependent manner. We 
described for the first time that sugar esters elevated the flux of the hydrophilic drug atenolol 
and the lipophilic efflux pump ligand vinblastine through Caco-2 cell layers, indicating the 
absorption enhancer properties of these surfactants. The penetration of the passive lipophilic 
drugs caffeine and antipyrine across Caco-2 layers was not changed by any of the tested 
surfactants. These data are in accordance with the study of Takaishi et al., in which the efflux 
pump ligand daunomycin permeability was also enhanced by sucrose esters in Caco-2 cells.24 
The absorption enhancing effects of sugar esters, especially laurate was demonstrated in 
several in vivo investigations.25-28 Moreover, many studies propose the use of sugar esters to 
enhance the penetration of molecules by the transdermal, nasal and ocular routes as reviewed 
by Szűts and Szabó-Révész.12 
Tween 80 and Cremophor RH40 did not influence fluorescein permeability in same 
concentrations as sugar esters, only in higher doses, indicating that sugar esters are more 
effective in small concentrations. Both reference surfactants enhanced the permeability of 
atenolol and vinblastine across epithelial cell layers. Other studies also showed that the 
application of Tween 80 increased the penetration of efflux pumps ligands,3 peptide 
molecules,56 dexamethasone and lucifer yellow55 through Caco-2 cell monolayers. Tween 80 
improves the absorption of drugs and is clinically applied in medicines as excipient (Fluxarix, 
Boostrix, Tubersol, and Tripedia). Our group demonstrated that Cremophor RH40 increases 
dextran permeability in nasal epithelial cell layers in vitro38 and in vivo57. Cremophor RH40 
is also used clinically in Neoral as an inactive ingredient beside cyclosporine A.  
In this study immunostaining of junctional proteins, fluorescent labeling of F-actin and 
transmission electron microscopy were used to visualize intercellular connections and 
demonstrate the integrity of the paracellular barrier. Cytoskeletal F-actin changes caused by 
an undefined sucrose ester were observed in Caco-2 cells,44 but junctional proteins or 
ultrastructure were not investigated. To our best knowledge it was observed for the first time 
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that sucrose esters, Tween 80 and Cremophor RH40 did not cause any major change in the 
distribution of immunostaining for junctional proteins claudin-1, ZO-1 and β-catenin on 
cultured Caco-2 cells at the applied concentrations. Our previous work showed a similar 
effect for Cremophor RH40 on Caco-2 cells.6 Surfactants slightly changed the organization of 
F-actin at the junctional (cortical actin ring) and basal part of the cells, but did not cause 
visible opening of the junctions. This F-actin redistribution can be linked to changes in the 
permeability of the junctions.4 The ultrastructure of Caco-2 cells was also investigated by 
electron microscopy, and the tested surfactants did not change the morphology of tight 
junctions. No disruption of junctions or cell layers were observed by these morphological 
examinations confirming the safety of the selected surfactant concentrations and that sugar 
esters do not cause visible damage of paracellular junctions. 
Surfactants modify the fluidity of cellular plasmamembranes, and this can contribute to 
enhanced membrane permeability and changes in the activity of membrane transporters and 
efflux pumps.58,59 Sucrose monoester of palmitic and stearic acid mixture decreased the 
membrane fluidity in vesicles of intestinal brush border membranes,60 but no data were 
available on cultured cells. We tested and compared the effects of sugar esters and reference 
surfactants on membrane fluidity in living Caco-2 cells. Sucrose esters fluidized the plasma 
membrane of cells at lower concentrations than reference absorption enhancers, and caused 
stronger TMA-DPH fluorescence anisotropy reduction than Tween 80 or Cremophor RH40. 
Sugar esters containing longer fatty acid chain, like palmitate and myristate, increased better 
the membrane fluidity at lower concentrations than laurate, indicating a correlation between 
the length of fatty acid chain of sugar esters and their effects on membrane fluidity.  
Considering together the results of resistance, impedance, permeability, morphology 
and membrane fluidity measurements we propose that several mechanisms contribute to the 
absorption enhancer effect of sugar esters (Fig. 6). All excipients increased the permeability 
of the tested passive permeability markers and drugs in cultured epithelial cells. Since plasma 
membrane fluidity was elevated by the surfactants, we hypothesize that this effect increase 
the transcellular passage of molecules. Tween 80 and Cremophor RH40 did not change the 
morphology of intercellular junctions visualized by immunostainings and did not modify 
epithelial resistance and impedance measurements suggesting that an increase in the 
paracellular transport of molecules can be excluded as a major mechanism of action. Sugar 
esters decreased both resistance and impedance indicating an effect on the function of 
intercellular junctions and the paracellular pathway. Thus it is proposed, that sugar esters 
enhance drug permeability through both the trans- and paracellular routes (Fig. 6).  
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Effects of sucrose esters on efflux pumps 
Efflux transporters hinder drug delivery across biological barriers and blocking these pumps 
is considered as a way to increase drug penetration.61 Surfactants were described to inhibit 
efflux pumps.62,63 The effect of sucrose esters on efflux pumps is contradictory with studies 
describing inhibitory29,30 or no effect24. In the present experiments sugar esters, unlike 
inhibitors and reference surfactants, increased the permeability of rhodamine 123 in apical to 
basal, but not in the other direction, suggesting no direct effect on efflux pumps. Sucrose 
esters elevated rhodamine 123 and calcein AM accumulation in co-treatment, but this effect 
alone do not indicate a direct inhibition of efflux transporters. We suggest that this increase in 
accumulation may be due to permeabilization of the plasma membrane or indirect inhibition 
of efflux pumps by changing the fluidity of cell membranes. Indeed, membrane cholesterol 
modulation by excipients is able to inhibit P-glycoprotein.64 Takaishi et al. supposed that 
elevated daunomycine flux in Caco-2 cells caused by sugar esters is due to permeabilization 
of the cellular membrane,24 but the present study is the first to experimentally prove it. 
Reference surfactants significantly increased the penetration of rhodamine 123 from 
apical to basal compartment but reduced the permeability in the other direction, similarly to 
inhibitors verapamil and cyclosporine A. Tween 80 and Cremophor RH40 also significantly 
increased the accumulation of rhodamine 123 in both pre- and co-treatment conditions. The 
uptake of calcein AM was increased by Tween 80 and the efflux pump inhibitors, but not by 
Cremophor RH40. The difference in the rhodamine and calcein AM uptake assays may be 
explained by the different specificity of the dyes: rhodamine 123 is a ligand of P-gp and 
BRCP while calcein AM is a ligand of P-gp and MRP-1 and -2.30,42,65 Our data indicate a 
direct inhibitory effect of these surfactants on efflux pump activity (Fig. 6) in agreement with 
other studies on Tween 80 3,29,30,62 and Cremophor RH4030,66. 
Conclusion 
Due to their favourable properties sugar esters are increasingly used as inactive ingredients in 
pharmaceutical products. Our study on cultured epithelial cells confirmed, that sucrose esters 
are effective absorption enhancers for both hydrophilic drugs and efflux pump ligands. Sugar 
esters enhance drug penetration by the trans- and paracellular routes, but do not directly 
inhibit efflux pumps. It was demonstrated for the first time that sucrose esters fluidize the 
plasma membrane of epithelial cells in low concentrations. Reference surfactants Tween 80 
and Cremophor RH 40 increase drug penetration by the transcellular pathway via membrane 
Page 19 of 43
John Wiley & Sons, Inc.
Journal of Pharmaceutical Sciences
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
fluidization and direct inhibition of efflux pump activity and not by acting on intercellular 
junctions. These data indicate that sucrose esters as oral excipients may act differently than 
the reference absorption enhancers, therefore further studies are needed to optimize oral 
dosage forms with these surfactants. 
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Table 1. Cellular toxicity of sugar esters and reference molecules 
Toxicity of P-1695, M-1695, D-1216 sucrose fatty acid esters and Tween 80, Cremophor 
RH40 reference absorption enhancers on human Caco-2 intestinal epithelial cells was 
measured by MTT dye conversion and LDH release methods after 24 hours of incubations. 
The MTT values were compared to non-treated group (100% viability). For LDH 
measurement groups were compared to the Triton-X 100 treated group (100% toxicity). TC 
0, non toxic concentration; TC 50, caused 50 % toxicity, TC 100, 100% cell death; n.a., not 
applicable. 
 
Table 2. Effect of surfactants on drug permeability 
Fold changes in the apparent permeability coefficients of atenolol, vinblastine, caffeine and 
antipyrine measured on confluent human Caco-2 intestinal epithelial cell layers after 1-hour 
treatment with P-1695, M-1695, D-1216 sucrose fatty acid esters and Tween 80, Cremophor 
RH40 reference absorption enhancers. Data are presented as mean ± S.D., n = 3; statistical 
analysis: ANOVA followed by Dunnett test; *P < 0.05, ***P < 0.001, all doses were 
compared to control. 
 
Table S1. Properties of surfactants 
R- carbon chain length, carbon chain length of fatty acid residues; CMC: critical micelle 
concentration; HLB: hydrophilic-lipophilic balance; US DMF, US drug master file.; Ph.Eur., 
European Pharmacopoea. 
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Legend to figures 
 
Figure 1. Effect of sucrose esters and reference surfactants on cellular viability 
Toxicity of M-1695, P-1695, D-1216 sucrose fatty acid esters (10 - 3000 µg/ml) and Tween 
80, Cremophor RH40 reference absorption enhancers (10 – 3000 µg/ml) on human Caco-2 
intestinal epithelial cells measured by (a) MTT dye conversion and (b) LDH release methods. 
The MTT values were compared to non-treated group (100% viability). For LDH 
measurement values were compared to the Triton-X 100 treated group (100% toxicity). Data 
are presented as mean ± S.D., n = 6; statistical analysis: ANOVA followed by Dunnett test; 
statistically significant differences (P < 0.05) were detected in the control group compared to 
the values measured in a: P-1695 group; b: M-1695 group; c: D-1216 group; e: Cremophor 
RH40 group. 
 
Figure 2. The effect of sucrose esters on impedance, resistance and 
fluorescein permeability of cell layers 
Effects of P-1695 (30 µg/ml), M-1695 (60 µg/ml), D-1216 (100 µg/ml) sucrose fatty acid 
esters and Tween 80 (1000 µg/ml), Cremophor RH40 (1000 µg/ml) reference absorption 
enhancers on (a) the impedance, (b) transepithelial electrical resistance and (c) fluorescein 
permeability on Caco-2 epithelial cells layer. Data are presented as mean ± S.D., n = 4; 
statistical analysis: ANOVA followed by Dunnett test. In case of (a) impedance measurement 
statistically significant differences were detected compared to the values measured in control 
group after treatment with P-1695 (# P < 0.05, ### P < 0.001); M-1695 (*P < 0.05, 
**P < 0.01); D-1216 (+ P < 0.05, +++ P < 0.001). Statistical analysis was also done at (b) 
TEER and (c) fluorescein permeability measurements by ANOVA followed by Dunnett test, 
***P < 0.001, all groups were compared to control. Abbreviations: C, control; P, P-1695; M, 
M-1695; D, D-1216; Tw, Tween 80; CR, Cremophor RH40. 
 
Figure 3. Effect of surfactants on cellular and junctional morphology, 
fluorescent immunostainings and electron microscopy 
(a) Immunostaining for tight and adherens junction membrane proteins claudin-1, zonula 
occludens-1 and β-cathenin and fluorescent staining for F-actin microfilaments in human 
Caco-2 intestinal epithelial cells after 1 hour treatment with sucrose esters and reference 
absorption enhancers. Bar for claudin-1, ZO-1 and β-cathenin is 20 µm and for F-actin is 15 
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µm. (b) Transmission electron microscopy at cell-cell connections after 1 hour treatment with 
sucrose esters and reference absorption enhancers; bar = 400 nm. Applied concentrations: M-
1695 at 60 µg/ml; P-1695 at 30 µg/ml; D-1216 at 100 µg/ml; Tween 80 at 1000 µg/ml; 
Cremophor RH40 at 1000 µg/ml. Abbreviations: C, control; M, M-1695; P, P-1695; D, D-
1216; Tw, Tween 80; CR, Cremophor RH40; ZO-1, zonula occludens protein-1; arrow: tight 
junction; AJ: adherence junction; DE: desmosome; ID: interdigitation.  
 
Figure 4. Effect of sucrose esters and reference surfactants on plasma 
membrane fluidity 
The effect on plasma membrane fluidity of (a) sucrose esters, (b) reference absorption 
enhancers and benzyl alcohol measured by TMA-DPH fluorescence anisotropy on living 
Caco-2 cell suspensions. The anisotropy values in control cells were between 0.293±0.002 
and 0.286±0.002 during the observation, and control value was considered as 100%. Data are 
presented as mean ± S.D., n = 6; statistical analysis: ANOVA followed by Dunnett test; 
***P < 0.001, all groups were compared to control. Applied concentrations of sugar esters: 1, 
10, 30, 60, 100 µg/ml; treatment dos s of reference surfactants: 1, 10, 100, 1000 µg/ml. 
Benzyl alcohol was used at 30 mM concentration. Abbreviations: P, P-1695; M, M-1695;D, 
D-1216; Tw, Tween 80; CR, Cremophor RH40; BA, benzyl alcohol. 
 
Figure 5. Effect of surfactants on efflux pump activity 
The effects of absorption enhancers on efflux pump activity measured by accumulation and 
permeability studies. The accumulation of efflux pump ligands (a) rhodamine 123, and (b) 
calcein AM was determined after the treatment with sucrose esters, reference absorption 
enhancers, verapamil and cyclosporin A on confluent Caco-2 cells. Treatments were carried 
out simultaneously. The effects of sucrose esters and reference absorption enhancers on the 
apparent permeability coefficients of rhodamine 123 in (c) apical-to-basal, (d) basal-to-apical 
directions and on the (e) efflux ratio of rhodamine 123 were measured on confluent Caco-2 
cell layers. Data are presented as mean ± S.D., n = 3-6; statistical analysis: ANOVA followed 
by Dunnett test; *P < 0.05, **P < 0.01, ***P < 0.001, all groups were compared to control. 
Applied concentrations: M-1695 at 60 µg/ml; P-1695 at 30 µg/ml; D-1216 at 100 µg/ml; 
Tween 80 at 1000 µg/ml; Cremophor RH40 at 1000 µg/ml; Verapamil at 100 µM; CycA, 
cyclosporine A at 10 µM. Abbreviations: Papp, apparent permeability coefficient; C, control; 
M, M-1695; P, P-1695; D, D-1216; Tw, Tween 80; CR, Cremophor RH40; Ver, verapamil; 
Cyc A, cyclosporine A. 
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Figure 6. How sucrose esters enhance permeability in epithelial cells? 
Sucrose esters and reference absorption enhancers may increase the penetration of molecules 
in several ways. (1) Surfactants enhance the dissolution of molecules and change plasma 
membrane fluidity which contribute to enhanced delivery of agents. (2) Reference surfactants, 
but not sugar esters, directly inhibit efflux transporters. (3) Sucrose esters may alter the 
function of cellular junctions, but reference molecules do not. Abbreviations: ABC tp, ABC 
efflux transporters; CR, Cremophor RH40; SE, sucrose esters; Tw, Tween 80; efflux pumps. 
 
Figure S1. Effect of sucrose esters and reference surfactants on fluorescein 
permeability  
The effect of sucrose esters and reference absorption enhancers on the apparent permeability 
coefficients of fluorescein on confluent Caco-2 cell layers applied in the same doses of (a) 
30 µg/ml, (b) 60 µg/ml, (c) 100 µg/ml. Data are presented as mean ± S.D., n = 3; statistical 
analysis: ANOVA followed by Dunnett test; ***P < 0.001, all groups were compared to 
control. Abbreviations: Papp, apparent permeability coefficient; C, control; P, P-1695; M, M-
1695; D, D-1216; Tw, Tween 80; CR, Cremophor RH40. 
 
Figure S2. Effects of surfactants, cytochalasin D and Triton X-100 on actin 
cytoskeleton 
Fluorescent staining for F-actin cytoskeletal protein with phalloidin labelled by Alexa Fluor 
488 in human Caco-2 intestinal epithelial cells after 1 hour treatment with sucrose esters, 
reference absorption enhancers, cytochalasin D or Triton X-100. Images were captured from 
two regions of cells after treatment with absorption enhancers: apical and basal part; and 
three different region of cells with treatment by cytochalasin D and Triton X-100: apical, 
junctional and basal part. Abbreviations: C, control; M, M-1695; P, P-1695; D, D-1216; Tw, 
Tween 80; CR, Cremophor RH40; CCD, cytochalasin D;TX, Triton X-100. Bar = 15 µm. 
 
Figure S3. Effect of surfactants on efflux pump activity at pre-treatment 
The pre-treatment effect of sucrose esters, reference absorption enhancers, verapamil and 
cyclosporin A on the accumulation of efflux pump ligand (a) rhodamine 123 and (b) calcein 
AM in confluent Caco-2 cell layers. Data are presented as mean ± S.D., n = 6; statistical 
analysis: ANOVA followed by Dunnett test; *P < 0.05, **P < 0.01, ***P < 0.001, all groups 
were compared to control. Applied concentrations: M-1695 at 60 µg/ml; P-1695 at 30 µg/ml; 
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D-1216 at 100 µg/ml; Tween 80 at 1000 µg/ml; Cremophor RH40 at 1000 µg/ml; Verapamil 
at 100 µM; CycA, cyclosporine A at 10 µM. Abbreviations: C, control; M, M-1695; P, P-
1695; D, D-1216; Tw, Tween 80; CR, Cremophor RH40; Ver, verapamil; Cyc A, 
cyclosporine A. 
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Table 1. Cellular toxicity of sugar esters and reference molecules 
 
 MTT dye conversion  LDH release 
Absorption 
enhancers 
TC 0 
(µg/ml) 
TC 50 
(µg/ml) 
TC 100 
(µg/ml) 
  
TC 0 
(µg/ml) 
TC 50 
(µg/ml) 
TC 100 
(µg/ml) 
P-1695 19 49 128   20 72 260 
M-1695 18 62 211   20 61 189 
D-1216 99 189 360   92 162 283 
Tween 80 473 1073 2432   1068 1229 1621 
Cremophor RH40 30900 33884 n.a.   2067 11810 44668 
n.a.: not applicable 
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Table 2. Effect of surfactants on drug permeability 
 
 
Passive 
hydrophilic 
Efflux 
substrate 
Passive lipophilic 
 Atenolol Vinblastine Caffeine Antipyrine 
P-1695 
30µg/ml 
1.46±0.02 *** 4.84±0.79 *** 1.01±0.01 0.95±0.06 
M-1695 
60µg/ml 
2.37±0.63 *** 25.92±2.74 *** 0.99±0.01 1.00±0.02 
D-1216 
100µg/ml 
1.58±0.08 *** 9.74±0.31 *** 0.98±0.03 0.99±0.03 
Tween 80 
1000µg/ml 
2.11±0.02 *** 10.74±0.67 *** 1.06±0.02 1.00±0.02 
Cremophor RH40 
1000µg/ml 
1.20±0.15 *** 3.96±0.59 * 1.00±0.03 0.98±0.01 
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The effect of sucrose esters on impedance, resistance and fluorescein permeability of cell layers  
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Effect of surfactants on cellular and junctional morphology, fluorescent immunostainings and electron 
microscopy  
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Table S1. Properties of surfactants 
 
 P-1695 M-1695 D-1216 
Chemical 
structure 
 
R- carbon 
chain lenght 16 14 12 
HLB 16 16 16 
CMC 28-250 µM 67 28-250 µM 67 500 µg/ml 68 
Trade name Ryoto sugar ester P-
1695 
Ryoto sugar ester M-
1695 
Surfhope SE Pharma D-
1216 (US DMF) 
Chemical 
name 
palmitate sucrose ester myristate sucrose ester laurate sucrose ester 
Solubility water soluble water soluble water soluble 
 
 
Polysorbate 80 (Ph.Eur.) Macrogol-glycerolhydroxystearate 
40 (Ph.Eur.) 
Chemical 
structure 
 
  
R- carbon 
chain lenght 
18 18 
HLB 15 15 
CMC 50-63µg/ml 51,56 390 µg/ml 48 
Trade name Tween 80 Cremophor RH40 
Chemical 
name 
polyethoxylatedsorbitan and oleic 
acid 
polyethoxylated 40 hydrogenated 
castor oil 
Solubility water soluble water soluble 
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